Earth Science Tech Reports Fiscal 2026 Revenue Growth and Higher Earnings

Earth Science Tech, Inc. (OTC: ETST) announced financial results for the fiscal year ended March 31, 2026, demonstrating continued growth across its integrated healthcare platform. The company reported revenue of $35.7 million, an 8% increase from the prior year, driven by expansion in telemedicine, pharmacy, and fulfillment services. Gross profit rose 5% to $25.5 million, while net income reached $3.6 million, up 11% compared with fiscal 2025. Total assets grew 27% year over year to $9.0 million, reflecting the company's strengthening balance sheet.

Management emphasized the company's capital allocation strategy, noting that it repurchased and retired more than 4 million shares during fiscal 2026 and more than 7.1 million shares through fiscal 2026 and subsequent periods. The company generated positive operating cash flow and strengthened its balance sheet without adding debt, positioning itself for future growth initiatives, product expansion, and continued share repurchases as it enters fiscal 2027.

Earth Science Tech operates as a diversified holding company focused on the health and wellness sector, building a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. The company's healthcare operations are supported by investments in real estate and asset management activities, as well as a consumer products business. The core value proposition lies in the seamless integration of patient care from consultation to fulfillment through the synergy of specialized subsidiaries.

For more details, the full press release is available at https://ibn.fm/NpjTw. The latest news and updates relating to ETST can be found in the company's newsroom at https://ibn.fm/ETST.